CFO and CEO got caught in the act? What is going on?
This is from seeking alpha:
OncoGenex Pharmaceuticals (OGXI) says that its chief executive officer, Scott Cormack, and its...
Monday, February 4, 6:48 PM ET
OncoGenex Pharmaceuticals (OGXI) says that its chief executive officer, Scott Cormack, and its chief financial officer, Michelle Burris, have both resigned from their positions, effective immediately, due to a personal conflict of interest with the company. Both revealed to the board of directors today that they've developed a personal relationship with one another that warranted a re-consideration of their reporting relationship and duties. Shares -3.4% AH.